Patel Chintu — SEC Form 4 filings
SEC reporting owner CIK 1737428. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-03-06 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO, Director | 6 | — | — | 23 |
Form 4 filings — Patel Chintu
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 6,381,734 | EDGAR |
| 2026-03-27 | 4/A | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 544,663 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 59,931 · Tax withholding (F): 17,112 @ $13.31 · Option exercise (M): 733,944 · Tax withholding (F): 315,885 @ $13.31 · Option exercise (M): 92,593 · Tax withholding (F): 28,983 @ $13.30 · +3 more | EDGAR |
| 2026-03-03 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 190,632 (derivative) @ $0 · Grant/award (A): 354,031 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 579,710 · Tax withholding (F): 274,307 @ $8.76 · Option exercise (M): 92,592 · Tax withholding (F): 46,528 @ $8.84 · Option exercise (M): 579,710 (derivative) @ $0 · Grant/award (A): 890,410 (derivative) @ $0 · +2 more | EDGAR |
| 2024-03-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 370,370 (derivative) @ $0 · Grant/award (A): 1,333,334 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1737428 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →